Global X Genomics & Biotechnology ETF GNOM

Medalist Rating as of | See Global X Investment Hub

Morningstar’s Analysis GNOM

Will GNOM outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Global X Genomics & Biotechnology ETF holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GNOM

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 45.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Guardant Health Inc

6.01 5M
Healthcare

Illumina Inc

5.06 4M
Healthcare

Twist Bioscience Corp

4.86 4M
Healthcare

10x Genomics Inc Ordinary Shares - Class A

4.56 4M
Healthcare

Natera Inc

4.51 4M
Healthcare

Bio-Techne Corp

4.25 4M
Healthcare

Veracyte Inc

4.18 4M
Healthcare

Moderna Inc

3.94 3M
Healthcare

Vertex Pharmaceuticals Inc

3.86 3M
Healthcare

BioMarin Pharmaceutical Inc

3.85 3M
Healthcare

Sponsor Center